aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. CBRS
4. HTZ
5. FDX
6. USO
7. SPY
8. KBH
9. LAES
10. GPUS

Go back to aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

aTyr Pharma (LIFE) PT Lowered to $16 at RBC Capital

March 15, 2024 6:39 AM EDT

RBC Capital analyst Kennan MacKay lowered the price target on aTyr Pharma (NASDAQ: LIFE) to $16.00 (from $19.00) while maintaining a Outperform rating.

The analyst comments "From LIFEs YE call, Early Access Program demand underscores the enthusiasm across sites as the ph.III EFZO-FIT... More